Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22978443 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting STAMPEDE: Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy: A Multi-Stage Multi-Arm Randomised Controlled Trial
Condition: Prostate Cancer
Interventions: Drug: celecoxib;   Drug: docetaxel;   Drug: prednisolone;   Drug: ADT;   Drug: zoledronic acid;   Drug: abiraterone;   Procedure: orchiectomy;   Radiation: Radiotherapy to the prostate;   Drug: enzalutamide

Indicates status has not been verified in more than two years